Shell Asset Management CO Myriad Genetics Inc Transaction History

Shell Asset Management CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$19.92 - $31.6 $382,523 - $606,814	-19,203 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$10.69 - $16.49 $34,507 - $53,229	3,228 Added 20.21%	19,203 $218,000
Q1 2020 May 11, 2020	SELL	$9.78 - $29.53 $2,376 - $7,175	-243 Reduced 1.5%	15,975 $229,000
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $8,644 - $14,496	-413 Reduced 2.48%	16,218 $442,000
Q3 2019 Nov 12, 2019	SELL	$22.08 - $47.08 $3,179 - $6,779	-144 Reduced 0.86%	16,631 $476,000
Q2 2019 Aug 12, 2019	SELL	$22.67 - $35.0 $8,682 - $13,405	-383 Reduced 2.23%	16,775 $466,000
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $38,122 - $63,784	-1,400 Reduced 7.54%	17,158 $499,000
Q2 2018 Aug 10, 2018	SELL	$27.75 - $40.17 $27,639 - $40,009	-996 Reduced 5.09%	18,558 $694,000
Q3 2017 Oct 20, 2017	SELL	$24.01 - $36.2 $847,865 - $1.28 Million	-35,313 Reduced 64.36%	19,554 $707,000
Q3 2017 Oct 18, 2017	BUY	$24.01 - $36.2 $1.32 Million - $1.99 Million	54,867	54,867 $2.12 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.